⌘K

Login Start Free

Home/Filings/4/0001144204-16-116710

4//SEC Filing

IMMUNE PHARMACEUTICALS INC 4

Accession 0001144204-16-116710

CIK 0001208261operating

View on SEC.gov Company Profile

Filed

Aug 3, 8:00 PM ET

Accepted

Aug 4, 9:41 PM ET

Size

4.8 KB

Accession

0001144204-16-116710

Insider Transaction Report

Form 4

Period: 2016-08-04

IMMUNE PHARMACEUTICALS INCIMNP

Luchi Monica E.

EVP & CMO

Transactions

Purchase
Common Stock
2016-08-04$0.45/sh+777,778$350,000→ 777,778 total

Footnotes (1)

[F1]Shares issued upon repayment of a $350,000 promissory note at the conversion price of $0.45 per share.

Documents

1 file

4
v446156_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

IMMUNE PHARMACEUTICALS INC

CIK 0001208261

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001208261

Filing Metadata

Form type: 4
Filed: Aug 3, 8:00 PM ET
Accepted: Aug 4, 9:41 PM ET
Size: 4.8 KB

View on SEC.gov